A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata

Fertility and Sterility
A J FriedmanI Schiff

Abstract

Thirty-eight premenopausal women with uterine leiomyomata were enrolled in a randomized, double-blind, placebo-controlled study evaluating the efficacy of depot leuprolide acetate (LA), a gonadotropin-releasing hormone agonist, in decreasing uterine volume. Eighteen women received intramuscular (IM) depot LA 3.75 mg every 4 weeks for 24 weeks (group A); 20 women received IM placebo with the same injection schedule (group B). Group A patients had a mean reduction in pretreatment uterine volume from 505 +/- 93 cu cm (mean +/- standard error of the mean) to 305 +/- 57 cu cm after 12 weeks (P less than 0.05 versus pretreatment) and 307 +/- 57 cu cm after 24 weeks of therapy (P less than 0.05 versus therapy (P less than 0.05 versus pretreatment). At 3 months after cessation of therapy, the mean uterine volume in group A had increased to 446 +/- 92 cu cm (P less than 0.05 versus week 24). Group B patients had no significant change in uterine volume over the 24-week treatment period. These results suggest that depot LA therapy may significantly decrease uterine volume in patients with leiomyomata, but that regrowth of uterine size occurs shortly after cessation of therapy.

Citations

Sep 7, 2017·Archives of Gynecology and Obstetrics·Antonio Simone LaganàSalvatore Giovanni Vitale
Jun 1, 1991·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·K BiberogluA Yildiz
Dec 1, 1990·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·G BenagianoK Elkind-Hirsch
Mar 1, 1994·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Z PuzigaćaZ Sretenović
Apr 1, 1996·The American Journal of Surgical Pathology·J J SreenanW R Hart
Sep 21, 2000·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·B A SilvaL Stevens
May 10, 2001·Clinical Obstetrics and Gynecology·M M Guarnaccia, M S Rein
Jan 18, 2006·Human & Experimental Toxicology·M NasiadekA Sapota
Feb 1, 1992·British Journal of Obstetrics and Gynaecology·D L Healy, B J Vollenhoven
Dec 1, 1993·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·L Mencaglia, C Tantini
Sep 30, 1994·Annals of the New York Academy of Sciences·J B Dubuisson, C Chapron
May 1, 1993·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M J Cooper
Jun 24, 1998·British Journal of Obstetrics and Gynaecology·A Pickersgill
Sep 17, 1999·Radiographics : a Review Publication of the Radiological Society of North America, Inc·E MuraseR W Tureck
May 12, 2001·Clinical Obstetrics and Gynecology·N F Chavez, E A Stewart
Jun 27, 2003·Environmental Health Perspectives·Gordon P FlakeDarlene Dixon
Nov 1, 2007·Expert Opinion on Investigational Drugs·Andrea C WilsonCraig S Atwood
Oct 16, 2012·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Sandeep P DeshmukhDonald G Mitchell
Dec 4, 2014·Obstetrics & Gynecology Science·Hyun Gyo LeeChi Heum Cho
Nov 1, 1991·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M A ThomasJ H Liu
Feb 1, 1995·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M GregoraB Hill
Dec 1, 1995·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·R MisaoT Tamaya
May 1, 1994·British Journal of Obstetrics and Gynaecology·M A Damario, J A Rock
Sep 1, 1995·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M A Damario, J A Rock
Jul 15, 2003·Current Opinion in Obstetrics & Gynecology·Eric S Surrey
May 24, 2008·Reproductive Sciences·Sang-Hoon KwonChi-Heum Cho
Oct 5, 2006·Obstetrics and Gynecology·Mamoru MorikawaHisanori Minakami
Mar 28, 2008·Nature Clinical Practice. Rheumatology·Mary Anne Dooley, Raj Nair
Oct 5, 2010·Women's Health·Ozgul Muneyyirci-DelaleSamy I McFarlane
Mar 23, 2011·Reproductive Sciences·Hilary RoederPhyllis C Leppert
Aug 16, 2015·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Sara M Drayer, William H Catherino
Nov 29, 2015·Cell and Tissue Research·Olga ProticPasquapina Ciarmela
May 22, 2018·BioMed Research International·Terrence D LewisWilliam H Catherino
Aug 29, 2012·Fertility and Sterility·Melissa GildenWilliam H Catherino
Sep 15, 2004·Fertility and Sterility·UNKNOWN Practice Committee of the American Society for Reproductive Medicine
Apr 1, 1994·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A H Ugwumadu, K Harding
Mar 20, 1999·Obstetrics and Gynecology Clinics of North America·J M Shwayder
Nov 29, 2002·Seminars in Roentgenology·Kevin J Sasadeusz, Robert T Andrews

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.